XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement of Previously Issued Unaudited Condensed Financial Statements - Statements of Cash Flows (Details) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (9,737,181) $ (5,234,063)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 1,542,338 3,434,944
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,144,221) (1,113,278)
Accounts payable 191,686 240,923
Accrued expenses (2,478,935) (350,315)
Net cash used in operating activities (11,626,313) (3,021,789)
Cash flows from financing activities:    
Proceeds from exercise of stock options 7,386 4,613
Net cash provided by financing activities 7,386 4,613
Net (decrease) increase in cash and cash equivalents (11,618,927) (3,017,176)
Cash and cash equivalents, beginning of period 28,377,693 45,686,014
Cash and cash equivalents, end of period $ 16,758,766 42,668,838
As Reported    
Cash flows from operating activities:    
Net loss   (5,894,213)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense   3,434,944
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets   (312,438)
Accounts payable   240,923
Accrued expenses   (491,005)
Net cash used in operating activities   (3,021,789)
Cash flows from financing activities:    
Proceeds from exercise of stock options   4,613
Net cash provided by financing activities   4,613
Net (decrease) increase in cash and cash equivalents   (3,017,176)
Cash and cash equivalents, beginning of period   45,686,014
Cash and cash equivalents, end of period   42,668,838
Restatement Impacts    
Cash flows from operating activities:    
Net loss   660,150
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets   (800,840)
Accrued expenses   $ 140,690